As opposed to IGFBP2, we observed a weak correlation between IGFBP6 and BMI, suggesting its potential utility as a marker for T2D development in women with other risk factors besides high BMI, such as compromised insulin production. This evidence concerns the gene IGFBP2 and type 2 diabetes mellitus.